Author Archives: Joana Carvalho

Muscles Controlling Eye Movements Not Affected by SMA, Study Finds

Adults with spinal muscular atrophy (SMA) usually do not experience weakness or impairment of any sort in the muscles controlling their eye movements, a recent study reported. When such impairments are present, they should prompt physicians to re-evaluate their initial diagnosis and consider the possibility that a patient may…

FDA Grants Rare Pediatric Disease Designation to SRK-015 for SMA

The U.S. Food and Drug Administration (FDA) has granted the designation of rare pediatric disease to SRK-015, an investigational treatment for spinal muscular atrophy (SMA), its developer, Scholar Rock, announced. This designation is given to therapies that are intended to treat serious or life-threatening disorders…

Imaging Tools to Guide Spinraza’s Use May Help Lower Complications

Adopting image-guided techniques may help physicians lower the risks of complications associated with the administration of Spinraza (nusinersen) in patients with spinal muscular atrophy (SMA), a study has found. Physicians caring for these patients should be familiar with the different techniques and possible complications of treatment administration, researchers…